comparemela.com

Latest Breaking News On - Boris peaker - Page 1 : comparemela.com

TD Cowen Upgrades MacroGenics (MGNX) to Buy, We Believe There Is Favorable Risk/Reward Heading Into The Efficacy Update By The End Of May

TD Cowen Upgrades MacroGenics (MGNX) to Buy, We Believe There Is Favorable Risk/Reward Heading Into The Efficacy Update By The End Of May
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Alpine Immune Sciences (ALPN) Named Best Idea for 2024 at TD Cowen

Alpine Immune Sciences (ALPN) Named Best Idea for 2024 at TD Cowen
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Eli Lilly extends tender offer deadline for Point Biopharma shares on low participation

Lilly set Dec. 15 as the deadline in a third extension. The Indianapolis-based drugmaker maintained its offer price at $12.50 per share, which is over 10% lower than Point Biopharma's last closing price of $13.80. Lilly had struck a $1.4 billion deal to buy Point Biopharma in October.

Eli Lilly extends tender offer deadline for Point Biopharma shares on low participation

(Reuters) - Eli Lilly on Monday again extended its deadline for Point Biopharma Global shareholders to sell their shares to the drugmaker, following .

Eli Lilly extends tender offer deadline for Point Biopharma shares on low participation

Eli Lilly extends tender offer deadline for Point Biopharma shares on low participation
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.